France: Clean Cells invests over €13m in new production site

Joseph Jammal, president and CEO of Clean Biologics

ArchiMed-backed Clean Cells, part of the Clean Biologics group, a provider of biopharmaceutical product quality control services and manufacturer of starting materials, is investing of €13m (US$15.3m) in a new production facility in Montaigu‑Vendée, France. The new plant will quadruple analysis and production capacity, becoming the largest site in Europe for biopharmaceuticals quality control services…

You must be a HMI Subscriber to view this content.

Subscribe Now »